搜索筛选:
搜索耗时3.1268秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
[期刊论文] 作者：Zahariy A Krastev,,
来源：World Journal of Gastroenterology 年份：2006
在长期的肝炎 B (HBV ) 感染的处理有重要进展，下列药为治疗被同意：常规干扰素(IFN ) ， pegylated 干扰素 alfa-2a (木钉 IFN alpha2a ) ， lamivudine， adefovir 和 entecavir。把...
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction
[期刊论文] 作者：Zahariy Krastev,Deian Jelev,Kr,
来源：世界胃肠病学杂志：英文版 年份：2016
We observed a sustained viral response(SVR) of ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin therapy, for 12 wk, in two cases with compensated live...
[期刊论文] 作者：Mihaela Petrova,Maria Muhtarova,Maria Nikolova,Svetoslav Magaev,Hristo Taskov,Diana Nikolovska,Zahariy Krastev,
来源：World Journal of Gastroenterology 年份：2006
AIM: To investigate reactivated Epstein-Barr virus (EBV) infection as a cause for chronic hepatitis. METHODS: Patients with occasionally established elevated se...
Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction
[期刊论文] 作者：Zahariy Krastev,Deian Jelev,Krasimir Antonov,Tanya Petkova,Evelina Atanasova,Nadezhda Zheleva,Bojidar,
来源：World Journal of Gastroenterology 年份：2016
We observed a sustained viral response(SVR) of ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin therapy, for 12 wk, in two cases with compensated live...
相关搜索：
